These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 17156488)

  • 1. A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells.
    Basu GD; Liang WS; Stephan DA; Wegener LT; Conley CR; Pockaj BA; Mukherjee P
    Breast Cancer Res; 2006; 8(6):R69. PubMed ID: 17156488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
    Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P
    Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice].
    Zuo CH; Li ZR; Zhou X; Ouyang YZ; Zhou ZY; Zeng L
    Ai Zheng; 2006 Apr; 25(4):414-20. PubMed ID: 16613672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human cytomegalovirus-encoded chemokine receptor US28 promotes angiogenesis and tumor formation via cyclooxygenase-2.
    Maussang D; Langemeijer E; Fitzsimons CP; Stigter-van Walsum M; Dijkman R; Borg MK; Slinger E; Schreiber A; Michel D; Tensen CP; van Dongen GA; Leurs R; Smit MJ
    Cancer Res; 2009 Apr; 69(7):2861-9. PubMed ID: 19318580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2 directly induces MCF-7 breast tumor cells to develop into exponentially growing, highly angiogenic and regionally invasive human ductal carcinoma xenografts.
    Robertson FM; Mallery SR; Bergdall-Costell VK; Cheng M; Pei P; Prosperi JR; Ferrari M
    Anticancer Res; 2007; 27(2):719-27. PubMed ID: 17465194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels.
    Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H
    Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer.
    Basu GD; Pathangey LB; Tinder TL; Lagioia M; Gendler SJ; Mukherjee P
    Mol Cancer Res; 2004 Nov; 2(11):632-42. PubMed ID: 15561779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential involvement of the cyclooxygenase-2 pathway in hepatocellular carcinoma-associated angiogenesis.
    Zhao QT; Yue SQ; Cui Z; Wang Q; Cui X; Zhai HH; Zhang LH; Dou KF
    Life Sci; 2007 Jan; 80(5):484-92. PubMed ID: 17097688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic tumoricidal effect between celecoxib and adenoviral-mediated delivery of mda-7 in human breast cancer cells.
    Suh YJ; Chada S; McKenzie T; Liu Y; Swisher SG; Lucci A; Hunt KK
    Surgery; 2005 Sep; 138(3):422-30. PubMed ID: 16213894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.
    Prosperi JR; Robertson FM
    Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
    Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP
    Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis.
    Kang KB; Wang TT; Woon CT; Cheah ES; Moore XL; Zhu C; Wong MC
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):888-96. PubMed ID: 17293239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of IL-8 in COX-2-mediated bone metastases from breast cancer.
    Singh B; Berry JA; Vincent LE; Lucci A
    J Surg Res; 2006 Jul; 134(1):44-51. PubMed ID: 16678856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.
    Patel MI; Subbaramaiah K; Du B; Chang M; Yang P; Newman RA; Cordon-Cardo C; Thaler HT; Dannenberg AJ
    Clin Cancer Res; 2005 Mar; 11(5):1999-2007. PubMed ID: 15756026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.
    Hiraga T; Myoui A; Choi ME; Yoshikawa H; Yoneda T
    Cancer Res; 2006 Feb; 66(4):2067-73. PubMed ID: 16489006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling.
    Lee A; Frischer J; Serur A; Huang J; Bae JO; Kornfield ZN; Eljuga L; Shawber CJ; Feirt N; Mansukhani M; Stempak D; Baruchel S; Glade Bender J; Kandel JJ; Yamashiro DJ
    Cancer Res; 2006 Apr; 66(8):4378-84. PubMed ID: 16618763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2-mediated regulation of VEGF-C in association with lymphangiogenesis and lymph node metastasis in lung cancer.
    Liu H; Yang Y; Xiao J; Lv Y; Liu Y; Yang H; Zhao L
    Anat Rec (Hoboken); 2010 Nov; 293(11):1838-46. PubMed ID: 20830783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 inhibition for the prophylaxis and treatment of preinvasive breast cancer in a her-2/neu mouse model.
    Tran-Thanh D; Buttars S; Wen Y; Wilson C; Done SJ
    Cancer Prev Res (Phila); 2010 Feb; 3(2):202-11. PubMed ID: 20103725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered gene expression profiles define pathways in colorectal cancer cell lines affected by celecoxib.
    Fatima N; Yi M; Ajaz S; Stephens RM; Stauffer S; Greenwald P; Munroe DJ; Ali IU
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3051-61. PubMed ID: 18957522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The potential role of Id1 in COX-2 mediated angiogenesis in gastric cancer].
    Lei T; Han S; Guo XY; Ding R; Li Y; Xie HH; Bai FH; Wu KC; Ding J
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1570-5. PubMed ID: 17785115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.